In 2020 prostate cancer was the most common cancer diagnosis and second leading cause of cancer death among American men with approximately 190,000 new diagnoses and over 33,000 deaths.
This equates to a 1 in 9 lifetime risk of getting prostate cancer and a 1 in 40 risk of dying from it. Fortunately, the risk of death has declined between 1993 and 2016 by 51% thanks to screening for prostate cancer. Prostate cancer screening includes both a prostate exam and a PSA blood test. The combination of these two tests offers improved diagnostic accuracy compared to either alone. The current guidelines recommend screening to begin after a discussion of the risks and benefits with your primary care physician or urologist.
The age to start screening is 45 for most men, but those with a family history, genetic predisposition or African ancestry should start at age 40. Screening should continue every 1-2 years until age 75, or older in select patients. If an abnormality is noted, then an MRI is often ordered. By using MRI, patients are able to avoid prostate biopsy almost 30% of the time and to improve diagnostic accuracy if the biopsy is needed.
Découvrez la suite de l’article ICI
Source : lompocrecord.com